ResmetiromIntervention2 papersPubChem 15981237 ↗LatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 2Oct 2026: 02Journal of HepatologyReview·29 SepEASL-EASD-EASO Guidance for the Use of Resmetirom and Semaglutide as MASH-Targeted TherapyMedicinaReview·28 SepCardiovascular-Kidney-Metabolic Syndrome and Its Hepatic Dimension: A Narrative Review
Journal of HepatologyReview·29 SepEASL-EASD-EASO Guidance for the Use of Resmetirom and Semaglutide as MASH-Targeted Therapy
MedicinaReview·28 SepCardiovascular-Kidney-Metabolic Syndrome and Its Hepatic Dimension: A Narrative Review